Keymed Biosciences Inc. (02162) has published its January 2026 monthly return, confirming an authorized share capital of 500,000,000 ordinary shares with a par value of USD 0.0001 each, totaling USD 50,000. The filing indicates no change from the preceding month.

The number of issued shares remained at 298,735,566 as of January 31, 2026, and there were no treasury shares. According to the announcement, the company continues to satisfy the applicable 25% public float requirement with no adjustments recorded during the period.